Authors


Patty Cheung

Latest:

Effective and Efficient Weighing of Potent Compounds

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.


Michael Moedler

Latest:

Accelerating Workforce Training on Single-Use Technologies

Training is crucial for supporting GMP operations in commercial-scale bioprocessing.


Jae Han Park, PhD

Latest:

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets

The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.


Nemera Services

Latest:

Patient Journey as a key to develop Inhalation combination products v3

Discover why integrating Human Factors and patient activities from early device to manufacturing is essential to develop a patient-centric inhaler.


Kevin M. Holman

Latest:

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets

The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.



S. Narasimha Murthy

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Cheryl Barton

Latest:

European Union Life Science Strategy

The European Union aims to become the most attractive place for life science by 2030.


Patrick Lavery

Latest:

CPHI Frankfurt to Show Innovations Driving Pharma Manufacturing Efficiency and Compliance

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product integrity, and regulatory compliance through automation and sustainable materials.


Oliver Luhn

Latest:

Using Excipients In Powder Formulations

During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.


Ammar Khawam

Latest:

Process Performance as a Means of Quality Management

Process performance metrics of eight different mechanical devices were assessed to evaluate compliance with regulatory and compendial criteria.



Harbinder Pordal

Latest:

Harnessing Predictive Simulation to Improve Mixing

Predictive computational methods are finding wider use in pharmaceutical solid dosage development, particularly in mixing and blending, to improve tech transfer and equipment selection, and speed the acquisition of process understanding.


Daniel S. Harding

Latest:

Establishing Systems Suitability and Validity Criteria for Analytical Methods and Bioassays

Ensuring reliable analytical methods and bioassays requires a well-thought-out strategy for evaluating method validity and systems suitability.


CPHI Frankfurt Content Team

Latest:

CPHI Frankfurt: Selecting the Right Outsourcing Strategy and Partner

Sponsors should explore key considerations ahead of choosing a new outsourcing partner.


Martha Sloboda

Latest:

The Growing Importance Of Release Liners In Pharmaceutical Manufacturing

With the increasing importance of novel dosage forms, the use of release liners as components of transdermal delivery systems, oral thin films and buccal mucosal systems is on the rise.


Sylvain Fleury

Latest:

Global Warming Heats Up Need for Malaria Vaccine

With economics and politics in the way, can we defeat the malaria epidemic before it defeats us?




Bianca Piachaud-Moustakis

Latest:

Improving Patient Access Through the UK IDAP Scheme

The IDAP pilot scheme is designed to accelerate access to innovative medical devices and is a pioneering legislative proposal in the UK medical device space.


Matthew Hewitt

Latest:

Exploring Best Practice Tech Transfer Methods for CGTs

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.


Maarten Lammens

Latest:

Handling Challenging Powders in Tableting Operations

Tests evaluated commercial rotary tablet presses to see how effectively they deal with problems such as poor flow, overlubrication, and capping.


Andreas Zimmer

Latest:

Printable Medicines: A Microdosing Device For Producing Personalized Medicines

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.


Melanie Beck

Latest:

New Technologies For Pharmaceutical Manufacturing: Addressing Cost, Containment And cGMP Requirements

New isolator and disposable technologies are set to assume a greater role in pharma manufacturing, according to a recent conference in Germany.



Andrea Kurz

Latest:

GMP/GDP Inspections: Challenges and Opportunities Revealed by the COVID-19 Pandemic

An annual survey on inspections and audits has revealed opportunities to use more flexible approaches to optimize processes.


Marco Adami

Latest:

Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing

Knowledge management has gained increasing importance in the pharmaceutical industry over the past 10–15 years


Christopher Turner

Latest:

Collaborative Efforts Address Key Data Integrity Challenges

Maintaining a quality culture across the diverse functions in a bio/pharmaceutical company is difficult. Representatives of the Quality Coordinating Committee of IQ Consortium report on collaborative efforts to address data integrity and the modernization of FDA’s good laboratory practice regulations.


Moritz Perscheid

Latest:

The Value of Primary Working Standards in Pharmaceutical Quality Control

It is argued that orthogonal quantitative methods can be used to establish primary working standards. An example details how to calculate the expanded measurement uncertainty (U) for the certified assay value by considering two orthogonal assay methods.


Mark Howard

Latest:

The Importance of Continued Investment in R&D

There has been a notable shift in interest for life-science companies over recent months from institutional investors investing through the public markets, but any plans to release further capital will rely on first-rate R&D.

© 2025 MJH Life Sciences

All rights reserved.